Concepedia

Publication | Open Access

NRG oncology RTOG 0625: a randomized phase II trial of bevacizumab with either irinotecan or dose-dense temozolomide in recurrent glioblastoma

70

Citations

16

References

2016

Year

References

YearCitations

Page 1